APA

Cai Q., Yang M., Liu D., Chen J., Shu D., Xia J., Liao X., Gu Y., Cai Q., Yang Y., Shen C., Li X., Peng L., Huang D., Zhang J., Zhang S., Wang F., Liu J., Chen L., Chen S., Wang Z., Zhang Z., Cao R., Zhong W., Liu Y. & Liu L. (2020). Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. : Engineering (Beijing, China).

Chicago

Cai Qingxian, Yang Minghui, Liu Dongjing, Chen Jun, Shu Dan, Xia Junxia, Liao Xuejiao, Gu Yuanbo, Cai Qiue, Yang Yang, Shen Chenguang, Li Xiaohe, Peng Ling, Huang Deliang, Zhang Jing, Zhang Shurong, Wang Fuxiang, Liu Jiaye, Chen Li, Chen Shuyan, Wang Zhaoqin, Zhang Zheng, Cao Ruiyuan, Zhong Wu, Liu Yingxia and Liu Lei. 2020. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. : Engineering (Beijing, China).

Harvard

Cai Q., Yang M., Liu D., Chen J., Shu D., Xia J., Liao X., Gu Y., Cai Q., Yang Y., Shen C., Li X., Peng L., Huang D., Zhang J., Zhang S., Wang F., Liu J., Chen L., Chen S., Wang Z., Zhang Z., Cao R., Zhong W., Liu Y. and Liu L. (2020). Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. : Engineering (Beijing, China).

MLA

Cai Qingxian, Yang Minghui, Liu Dongjing, Chen Jun, Shu Dan, Xia Junxia, Liao Xuejiao, Gu Yuanbo, Cai Qiue, Yang Yang, Shen Chenguang, Li Xiaohe, Peng Ling, Huang Deliang, Zhang Jing, Zhang Shurong, Wang Fuxiang, Liu Jiaye, Chen Li, Chen Shuyan, Wang Zhaoqin, Zhang Zheng, Cao Ruiyuan, Zhong Wu, Liu Yingxia and Liu Lei. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. : Engineering (Beijing, China). 2020.